Streetbeat News

RGC

Regencell Bioscience Holdings Limited

https://www.regencellbioscience.com

Industry

Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Open

12.85

Mkt cap

241M

Volume

2.7M

High

19.79

P/E Ratio

-56.06

52-wk high

32.44

Low

12.71

Div yield

N/A

52-wk low

3.03

In Friday's pre-market session, several healthcare stocks experienced significant movements. Notable gainers included NewGenIvf Group (NIVF) with a 71.8% increase, Conduit Pharmaceuticals (CDT) up by 40.77%, and Kindly MD (KDLY) rising by 17.76%. On the losing side, Carmell (CTCX) fell by 12.4%, Jin Medical International (ZJYL) decreased by 8.74%, and LakeShore Biopharma (LSB) dropped by 8.14%.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:07 pm

In Thursday's after-market session, several health care stocks experienced significant price movements. Notable gainers included NewGenIvf Group (NIVF) with a 58.1% increase, and SunLink Health Systems (SSY) with a 17.13% rise. On the losing side, Klotho Neurosciences (KLTO) fell by 6.5%, and Humana (HUM) declined by 4.76%.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 8:31 pm

Several healthcare stocks experienced significant price movements during Thursday's intraday session. Notable gainers included TransCode Therapeutics, Vaccinex, and NexGel, while Gritstone Bio and 10x Genomics were among the biggest losers.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 4:31 pm

Several healthcare stocks experienced significant price movements during Tuesday's intraday session. Ontrak, Regional Health Props, Bio-Path Holdings, Portage Biotech, Regencell Bioscience, and Shattuck Labs saw notable gains, while Vincerx Pharma, TransCode Therapeutics, LogicMark, Galecto, Beyond Air, and Instil Bio experienced declines.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 4:31 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Scholar Rock Holding (SRRK) saw a massive increase of 198.1%, while Trevena (TRVN) experienced a sharp decline of 45.5%. Other notable gainers include LogicMark (LGMK) and Biohaven (BHVN), while Entero Therapeutics (ENTO) and Onconetix (ONCO) were among the losers.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 12:08 pm

U.S. stocks traded higher with the Dow Jones index gaining over 300 points. The trade deficit in the U.S. narrowed to $73.1 billion in June. VBI Vaccines, Regencell Bioscience, and Lumen Technologies saw significant stock price increases, while Elevation Oncology, Jumia Technologies, and ThredUp experienced notable declines.

Portfolio Pulse from Avi Kapoor

August 06, 2024 | 2:22 pm

Saia, Inc. (NASDAQ:SAIA) shares fell 18.6% after reporting worse-than-expected Q2 earnings and sales. Other notable movers include BurgerFi International, Inc. (NASDAQ:BFI) up 117.4% after a legal settlement, and DexCom, Inc. (NASDAQ:DXCM) down 40.7% due to disappointing Q2 revenue and weak FY24 guidance.

Portfolio Pulse from Avi Kapoor

July 26, 2024 | 5:26 pm

Edwards Lifesciences Corporation (NYSE:EW) shares fell sharply after reporting worse-than-expected Q2 sales and issuing weak Q3 guidance. Despite beating EPS estimates, the stock dipped 26.9%. The company also acquired JenaValve and Endotronix. Other notable movers include Predictive Oncology Inc. (NASDAQ:POAI), Psyence Biomedical Ltd. (NASDAQ:PBM), and Ford Motor Company (NYSE:F).

Portfolio Pulse from Avi Kapoor

July 25, 2024 | 6:12 pm

Indivior PLC (NASDAQ:INDV) shares surged 14.5% in pre-market trading after reporting better-than-expected Q2 earnings and announcing a $100 million share repurchase program. Other notable pre-market movers include Psyence Biomedical Ltd. (NASDAQ:PBM), BloomZ Inc. (NASDAQ:BLMZ), and 2U, Inc. (NASDAQ:TWOU), among others.

Portfolio Pulse from Avi Kapoor

July 25, 2024 | 10:36 am

Enphase Energy shares rose 6.2% in pre-market trading despite missing Q2 revenue and earnings estimates. Other notable pre-market movers include Dermata Therapeutics, NuZee, Regencell Bioscience, Allarity Therapeutics, NewGenIvf Group, Perfect Moment, ENGlobal Corporation, 1847 Holdings, and Seagate Technology among gainers, while Azitra, Conn’s, Verastem, ATI Physical Therapy, Volato Group, Chijet Motor, AtlasClear Holdings, Wheels Up Experience, SFL Corporation, and Tesla saw declines.

Portfolio Pulse from Avi Kapoor

July 24, 2024 | 9:27 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.